search buttonmobile navigation expand button

Need Assistance?












Back to Search Results

RTOG 0924

Title
RTOG 0924, Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial.
Description
The purpose of this study is to compare the effects of hormone therapy (androgen deprivation) and radiation therapy to the prostate gland and seminal vesicles with hormone therapy and radiation therapy to the whole pelvic body area on prostate cancer to find out which is better.
Trial Information
Principal Investigator: Dr. Kiran Devisetty

Contact: MCI: McLaren Center for Research & Innovation:(248) 484-4960
MCRI@mclaren.org

IRB Number: MCI:2012-00084
clinicaltrials.gov: 01368588

More Information: